Dolutegravir and rilpivirine (Oral)
Medically reviewed on Oct 4, 2018
Commonly used brand name(s)
In the U.S.
Available Dosage Forms:
Therapeutic Class: Antiretroviral Agent
Pharmacologic Class: Integrase Inhibitor
Uses For dolutegravir and rilpivirine
Dolutegravir and rilpivirine combination is used to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). It is given to patients to replace their current anti-HIV medicines when their healthcare provider determines that they meet certain requirements.
Dolutegravir and rilpivirine will not cure HIV infection or AIDS. It works by lowering the amount of HIV in the blood and it will also help your immune system. This may help delay some of the medical conditions that usually result from AIDS or HIV disease. It will not keep you from spreading HIV to other people.
Dolutegravir and rilpivirine is available only with your doctor's prescription.
Before Using dolutegravir and rilpivirine
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For dolutegravir and rilpivirine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to dolutegravir and rilpivirine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of combination in dolutegravir and rilpivirine combination in the pediatric population. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of dolutegravir and rilpivirine combination in the elderly. However, elderly patients are more likely to have age-related kidney, liver, or heart problems, which may require caution in the dose for patients receiving dolutegravir and rilpivirine.
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with Medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking dolutegravir and rilpivirine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using dolutegravir and rilpivirine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
- St John's Wort
Using dolutegravir and rilpivirine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
- Aluminum Carbonate, Basic
- Aluminum Hydroxide
- Aluminum Phosphate
- Arsenic Trioxide
- Calcium Carbonate
- Dihydroxyaluminum Aminoacetate
- Dihydroxyaluminum Sodium Carbonate
- Eslicarbazepine Acetate
- Magnesium Carbonate
- Magnesium Hydroxide
- Magnesium Oxide
- Magnesium Trisilicate
- Sodium Bicarbonate
- St John's Wort
Using dolutegravir and rilpivirine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Interactions with Food/Tobacco/Alcohol
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other Medical Problems
The presence of other medical problems may affect the use of dolutegravir and rilpivirine. Make sure you tell your doctor if you have any other medical problems, especially:
- Depression or
- Hepatitis B or C infection, history of or
- Mental illness, history of—Use with caution. May make these conditions worse.
- Kidney disease, severe or end-stage—Use with caution. May cause side effects to become worse.
Proper Use of dolutegravir and rilpivirine
Take dolutegravir and rilpivirine exactly as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered.
Dolutegravir and rilpivirine comes with a patient information leaflet. Read and follow the instructions carefully. Ask your doctor if you have any questions.
Keep taking dolutegravir and rilpivirine for the full time of treatment, even if you begin to feel better. Do not stop taking it without checking first with your doctor. When your supply of the medicine is running low, contact your doctor or pharmacist ahead of time. Do not allow yourself to run out of the medicine.
It is best to take dolutegravir and rilpivirine with food.
Take dolutegravir and rilpivirine at least 4 hours before or 6 hours after you take antacids, laxatives, or other products that contain aluminum, calcium, magnesium, or sucralfate.
Take dolutegravir and rilpivirine at least 4 hours before or 12 hours after you take a stomach medicine for heartburn or ulcers (eg, cimetidine, famotidine, nizatidine, ranitidine, Axid®, Pepcid®, Tagamet®, or Zantac®).
If you take iron or calcium supplements, you may take these supplements at the same time that you take dolutegravir and rilpivirine with food or at least 4 hours before or 6 hours after you take dolutegravir and rilpivirine.
The dose of dolutegravir and rilpivirine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of dolutegravir and rilpivirine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
- For oral dosage form (tablets):
- For treatment of HIV infection:
- Adults—1 tablet once a day with food. For patients who are also taking dolutegravir and rilpivirine together with rifabutin, take an additional 25 milligrams (mg) tablet of rilpivirine (Edurant®) once a day.
- Children—Use and dose must be determined by your doctor.
- For treatment of HIV infection:
If you miss a dose of dolutegravir and rilpivirine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Store the medicine in the original bottle. Keep it tightly closed.
Precautions While Using dolutegravir and rilpivirine
It is very important that your doctor check your progress at regular visits to make sure dolutegravir and rilpivirine is working properly. Blood tests may be needed to check for unwanted effects.
Dolutegravir and rilpivirine does not decrease the risk of transmitting HIV infection to others through sexual contact or by contamination through blood. HIV may be acquired from or spread to others through infected body fluids, including blood, vaginal fluid, or semen. If you are infected, it is best to avoid any sexual activity involving an exchange of body fluids with other people. If you do have sex, always wear (or have your partner wear) a condom (“rubber”). Also, do not share needles or equipment with anyone or use dirty needles. If you have any questions about this, talk with your doctor.
Dolutegravir and rilpivirine should not be used together with dexamethasone (Decadron®), dofetilide (Tikosyn®), certain seizure medicines (eg, carbamazepine, oxcarbazepine, phenobarbital, phenytoin, Dilantin®, Tegretol®, Trileptal®), medicine for tuberculosis (eg, rifampin, rifapentine, Priftin®, Rifadin®, Rimactane®), certain stomach medicines (eg, esomeprazole, lansoprazole, omeprazole, pantoprazole, rabeprazole, Aciphex®, Nexium®, Prevacid®, Prilosec®). or St. John's wort.
Dolutegravir and rilpivirine may cause a serious type of allergic reaction called including anaphylaxis and drug reaction with eosinophilia and systemic symptoms (DRESS syndrome). Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor right away if you or your child have a rash, itching, hoarseness, lightheadedness or dizziness, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth with dolutegravir and rilpivirine.
Dolutegravir and rilpivirine may cause serious liver problems. This may occur in patients with hepatitis B or C infection. Check with your doctor right away if you or your child have more than one of these symptoms: clay-colored stools, dark urine, a decreased appetite, fever, headache, itching, nausea and vomiting, skin rash, stomach pain or tenderness, swelling of the feet or lower legs, unusual tiredness or weakness, or yellow eyes or skin.
Tell your doctor right away if you start to feel depressed and have thoughts about hurting yourself. Report any unusual thoughts or behavior that troubles you, especially if they are new or get worse quickly.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Dolutegravir and rilpivirine Side Effects
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
- Abnormal dreams
- cloudy or bloody urine
- dark urine
- decreased frequency or amount of urine
- depressed mood
- gaseous stomach pain
- general feeling of tiredness or weakness
- increased blood pressure
- increased thirst
- light-colored stools
- loss of appetite
- lower back or side pain
- recurrent fever
- severe nausea or vomiting
- stomach fullness
- stomach pain
- suicidal thoughts, attempt, or behavior
- swelling of the face, fingers, feet, or lower legs
- trouble sleeping
- troubled breathing
- unusual tiredness or weakness
- upper right abdominal pain
- weight gain
- yellow eyes or skin
Incidence not known
- Decreased appetite
- difficulty swallowing
- fast heartbeat
- skin itching, rash, or redness
- stomach tenderness
- stomach pain, continuing
- swelling of the face, throat, or tongue
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- Bloated feeling
- excess air or gas in the stomach or bowels
- feeling of fullness
- muscle pain
- passing gas
- sleepiness or unusual drowsiness
Incidence not known
- Difficulty in moving
- joint pain or swelling
- muscle ache, cramp, or stiffness
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 2018 Truven Health Analytics, Inc. All Rights Reserved.
More about dolutegravir/rilpivirine
- Dolutegravir/rilpivirine Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- Drug class: antiviral combinations
Other brands: Juluca
- Dolutegravir Sodium and Rilpivirine Hydrochloride (AHFS Monograph)
- Dolutegravir and Rilpivirine (Wolters Kluwer)